Nomura Holdings’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7,000
| Closed | -$223K | – | 1032 |
|
|
2024
Q4 | $223K | Buy |
+7,000
| New | +$223K | ﹤0.01% | 1370 |
|
|
2024
Q1 | – | Sell |
-14,695
| Closed | -$880K | – | 971 |
|
|
2023
Q4 | $880K | Buy |
+14,695
| New | +$880K | ﹤0.01% | 646 |
|
|
2023
Q3 | – | Sell |
-31,186
| Closed | -$2.84M | – | 802 |
|
|
2023
Q2 | $2.84M | Buy |
+31,186
| New | +$2.84M | 0.01% | 253 |
|
|
2023
Q1 | – | Sell |
-59,465
| Closed | -$3.07M | – | 903 |
|
|
2022
Q4 | $3.07M | Buy |
59,465
+3,295
| +6% | +$170K | 0.01% | 345 |
|
|
2022
Q3 | $3.83M | Buy |
+56,170
| New | +$3.83M | 0.02% | 346 |
|
|
2022
Q2 | – | Sell |
-104,067
| Closed | -$5.72M | – | 1366 |
|
|
2022
Q1 | $5.72M | Buy |
104,067
+90,576
| +671% | +$4.98M | 0.02% | 332 |
|
|
2021
Q4 | $640K | Sell |
13,491
-271,009
| -95% | -$12.9M | ﹤0.01% | 914 |
|
|
2021
Q3 | $9.56M | Buy |
284,500
+238,000
| +512% | +$8M | 0.02% | 248 |
|
|
2021
Q2 | $2.94M | Buy |
46,500
+32,500
| +232% | +$2.06M | 0.01% | 473 |
|
|
2021
Q1 | $600K | Sell |
14,000
-7,300
| -34% | -$313K | ﹤0.01% | 931 |
|
|
2020
Q4 | $1.22M | Buy |
+21,300
| New | +$1.22M | ﹤0.01% | 641 |
|
|
2020
Q3 | – | Sell |
-8,500
| Closed | -$277K | – | 952 |
|
|
2020
Q2 | $277K | Sell |
8,500
-145,500
| -94% | -$4.74M | ﹤0.01% | 696 |
|
|
2020
Q1 | $4.13M | Buy |
+154,000
| New | +$4.13M | 0.02% | 188 |
|
|
2019
Q4 | – | Sell |
-16,000
| Closed | -$355K | – | 721 |
|
|
2019
Q3 | $355K | Buy |
+16,000
| New | +$355K | ﹤0.01% | 624 |
|